Physicians' views of formularies: Implications for Medicare drug benefit design

被引:12
|
作者
Landon, BE [1 ]
Reschovsky, JD
Blumenthal, D
机构
[1] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[2] Beth Israel Deaconess Med Ctr, Washington, DC USA
[3] Ctr Studying Hlth Syst Change, Washington, DC USA
[4] Inst Hlth Policy, Boston, MA USA
[5] Massachusetts Gen Hosp, Partners HealthCare Syst, Boston, MA 02114 USA
关键词
D O I
10.1377/hlthaff.23.1.218
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
As Congress considers introducing a drug benefit for Medicare, it will more than likely adopt a program that uses a formulary. We examined data from the Community Tracking Study Physicians Survey, a large, nationally representative study of physicians, to learn about physicians' views of formularies. Our results suggest that several aspects of formularies are associated with physicians' positive views about them. Policymakers should consider imposing limits on the number of competing Medicare formularies operating in a particular area, promoting the adoption and use of information technology, and incorporating financial incentives for physicians to adhere to formularies.
引用
收藏
页码:218 / 226
页数:9
相关论文
共 50 条